Determining the Impact of Dementia and Executive Impairment on Antidepressant Treatment Response in Older Persons
Overview
- Phase
- Phase 4
- Intervention
- Zoloft (antidepressant)
- Conditions
- Depression
- Sponsor
- Unity Health Toronto
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- depression
- Status
- Completed
- Last Updated
- 14 years ago
Overview
Brief Summary
Major depression is a very common health problem affecting older persons. The present standard of treatment is with medications called "antidepressants". Antidepressants have been studied extensively in older persons with normal brain function and have been shown to be effective. However, certain types of brain dysfunction called "executive impairment" (inability to do higher order thinking) may lead to poor treatment outcomes. This study will compare how older depressed people with different levels of executive impairment respond differently to standard antidepressant treatment. Knowing this information will lead to more rational targeting of available treatments, leading to improved treatment outcomes.
Investigators
Eligibility Criteria
Inclusion Criteria
- •above the age of 65,
- •speak English fluently,
- •experience depression, AND
- •not yet on active treatment.
Exclusion Criteria
- •active delirium,
- •substance abuse,
- •mental illness other than major depression,
- •active CNS disease,
- •unstable systematic medical disease, OR
- •current of past psychotic disorder.
Arms & Interventions
zoloft
Both arms of the study will include zoloft. However, the treatment response to zoloft will be compared in two different subgroups.
Intervention: Zoloft (antidepressant)
Outcomes
Primary Outcomes
depression
Time Frame: June 1, 2007 - June 1, 2008